StockpollyBeta
Get App
Popularity #2,026
ALTO · NASDAQ · Chemicals - Specialty

Alto (ALTO)

Makes specialty alcohols and essential ingredients for health, food, and renewable-fuel markets.

$3.83
After hours+0.02 (+0.52%)
At close$3.81(−2.56%)

  1. Alto Ingredients: Profit Is Still Cyclical But Valuation Is Becoming Interesting

    Seeking Alpha

  2. Will Alto Ingredients' Higher Maintenance Costs Pressure Margins?

    Zacks Investment ResearchEarnings

  3. Can Alto Ingredients Sustain Gains as Alcohol Premiums Narrow?

    Zacks Investment ResearchOther

  4. Can Alto Ingredients' Export Challenges Weigh on Growth Outlook?

    Zacks Investment ResearchOperations

  5. Should You Buy, Hold or Sell Alto Ingredients Stock Post Q2 Earnings?

    Zacks Investment Research

  6. Dimensional Fund Advisors LP Purchases 281,833 Shares of Alto Ingredients, Inc. $ALTO

    Defense World

  7. Can 45Z Tax Credits Become Alto Ingredients' Next Earnings Driver?

    Zacks Investment Research

  8. Alto Ingredients: Strong Quarter, Decent Prospects - Buy The Dip

    Seeking Alpha

  9. Why Does Alto Ingredients' Q2 EBITDA Surge Signal a Turnaround?

    Zacks Investment Research

  10. ALTO Q2 Earnings Call Highlights Margin Recovery and 45Z Focus

    Zacks Investment Research

  11. Alto Ingredients, Inc. (ALTO) Q2 2026 Earnings Call Transcript

    Seeking Alpha

  12. Alto Ingredients (ALTO) Q2 Earnings and Revenues Top Estimates

    Zacks Investment Research

  13. Alto Ingredients Q2 Earnings Call Highlights

    MarketBeat

  14. Alto Ingredients, Inc. Reports Second Quarter 2026 Results

    GlobeNewsWire

  15. Alto Ingredients: Strong Margin Expansion Is Driving Above-Average Earnings Growth

    Seeking Alpha

  16. Alto Neuroscience: Buy ALTO-207 Advancement TRD And Other Expansion Indications

    Seeking Alpha

  17. Alto Ingredients, Inc. to Release Second Quarter 2026 Financial Results on August 5, 2026

    GlobeNewsWire

  18. How Alto Ingredients Plans to Monetize Every Ton of Biogenic CO2

    Zacks Investment Research

  19. Could E15 Adoption Unlock Alto Ingredients' Next Growth Phase?

    Zacks Investment Research

  20. ALTO Trades at a Discount Despite 344% Rally in a Year: What's Next?

    Zacks Investment Research